A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
J1I-MC-GZQF
Phase 1 other active
Quick answer
A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia for Type 2 Diabetes Mellitus is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 1
- Modality
- other
- Status
- active